The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...

With obesity rates rising in India, the market for weight loss drugs has grown exponentially in the country. Novo Nordisk's oral semaglutide tablet, Rybelsus, launched in India in January 2022 ...

In India, there were 32 centres and 788 people enrolled. Semaglutide was initially approved in June 2021 for chronic weight management in those with obesity or overweight and at least one weight ...

A recent clinical trial, led by UNC School of Medicine researchers Dr. John Buse and Dr. Matthew Cavender, found that the oral form of semaglutide significantly reduces the risk of cardiovascular ...

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list. Hundreds of ...

Half of the participants took a semaglutide tablet daily and half took a placebo. Participants continued their assigned regimen for an average of just under four years. By the end of the trial ...

There’s limited scientific evidence directly linking semaglutide use to vitamin B12 deficiency or recommending routine vitamin B12 supplementation for people taking semaglutide. Semaglutide is ...

Semaglutide increased maximum walking distance by 13% compared with placebo. Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic ...

Obesity rates have been increasing in the US for decades, but in 2023 they fell – at least in part because of the burgeoning popularity of the “miracle drug” semaglutide. Approved for ...